Showing results (4171-4180 of 45,233) with videos related to
Sort By:
Pageof 4,524
Cancer Research|April 17, 2014
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγPing-Chih Ho, Katrina M Meeth, Yao-Chen Tsui, et al.Cancer Research|April 17, 2014
Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinomaRanran Wang, Wei Liu, Christine M Helfer, et al.Cancer Research|April 22, 2014
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signalingMarie Schoumacher, Kristen E Hurov, Joseph Lehár, et al.Cancer Research|April 22, 2014
Enhancement of the T-cell armamentarium as a cell-based therapy for prostate cancerW Nathaniel Brennen, Charles G Drake, John T IsaacsCancer Research|September 15, 1989
Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potentialG Bevilacqua, M E Sobel, L A Liotta, et al.Cancer Research|September 15, 1989
Dose escalation study of recombinant human granulocyte-colony-stimulating factor (KRN8601) in patients with advanced malignancyK Eguchi, S Sasaki, T Tamura, et al.Cancer Research|October 1, 1989
Modulation by adriamycin, daunomycin, verapamil, and trifluoperazine of the biochemical processes linked to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetateK Satyamoorthy, J P PerchelletCancer Research|May 1, 1989
Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumorsP E Mansson, P Adams, M Kan, et al.Cancer Research|April 3, 2014
VISTA is an immune checkpoint molecule for human T cellsJ Louise Lines, Eirini Pantazi, Justin Mak, et al.Cancer Research|April 3, 2014
VISTA Regulates the Development of Protective Antitumor ImmunityIsabelle Le Mercier, Wenna Chen, Janet L Lines, et al.Pageof 4,524